Efficacy and safety of vamorolone in Duchenne muscular dystrophy:  An 18-month interim analysis of a non-randomized open-label extension study

This report covers the initial 24-week trial and the first 12 months of the VBP15-LTE trial (total treatment period 18 months). DMD trial participants (males, 4 to

Source: PLoS Medicine - September 20, 2020 Category: Internal Medicine Authors: Edward C. Smith Source Type: research